ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentEpalingesND BioSciences SA
ND BioSciences SA Logo
Verified· 4 sources

ND BioSciences SA

Summary

About the company

ND BioSciences SA develops next-generation therapeutics and diagnostic assays for neurodegenerative diseases using validated and patented protein‑engineering and cellular drug‑discovery platforms. The company, a spin-off from the École polytechnique fédérale de Lausanne (EPFL), applies models that reproduce pathogenic protein aggregates and aggregation stages to support drug and biomarker development.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered5
Platforms for protein engineering and drug discovery
Platforms for chemical protein synthesis and reproduction of pathological protein forms for drug and biomarker discovery in neurodegenerative diseases, including α-synuclein, Tau, Huntingtin and TDP43.
Therapeutic development programmes for neurodegenerative diseases
Development of therapies and combination therapies for neurodegenerative diseases, focusing on inhibition of aggregation, clearance of existing aggregates, and blocking uptake and spread of pathological aggregates.
Research platforms for preclinical models
Cell-free, cellular, neuronal and animal models for analyzing protein aggregation kinetics, toxicity, Lewy body formation, mechanism of action and efficacy of potential therapeutic molecules.
Biomarker discovery for neurodegenerative diseases
Development of relevant targets and assays for biomarker discovery, early diagnosis and monitoring of disease progression in Parkinson, Alzheimer and Huntington.
Research partnerships
Collaborations with external partners to provide synuclein protein proteoforms, to accelerate assays and to develop diagnostics and therapeutics.
Reviews

Aggregated rating

Aggregated rating
5
of 5

Aggregated from 1 reviews across all connected sources

Sources
GGoogle51
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

February 14, 2020Media
Award winning ND BioSciences joins StartLab
startupticker.ch

Knowledge

No knowledge articles yet

Once ND BioSciences SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

ND BioSciences SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank ND BioSciences SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of ND BioSciences SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Route de la Corniche 5
1066 Epalinges
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-197.994.328
Founded
2019 · 7 years
Last commercial register change
March 26, 2019
Employees
1 to 10

Similar companies

AI
AC Immune SA
Lausanne
BT
bNovate Technologies SA
Ecublens Vd
SS
Swisslabnat Sàrl
Lutry
SS
Synature SA
Lausanne